As of Friday close, Definitive Healthcare Corp.’s (NASDAQ:DH) stock was down -$0.1, moving down -1.00 percent to $9.90. The average number of shares traded per day over the past five days has been 643,620 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.65 fall in that time frame. In the last twenty days, the average volume was 506,810, while in the previous 50 days, it was 643,140.
Since last month, DH stock retreated -14.51%. Shares of the company fell to $9.50 on 08/15/23, the lowest level in the past month. A 52-week high of $22.56 was reached on 02/02/23 after having rallying from a 52-week low of $8.71. Since the beginning of this year, DH’s stock price has dropped by -9.92% or -$1.09, and marked a new high 6 times. However, the stock has declined by -56.12% since its 52-week high.
DH stock investors should be aware that Definitive Healthcare Corp. (DH) stock had its last reported insider trading activity 99 days ago on May 12. SEA VII Management, LLC, the Director of the company, disposed of 6,240 shares for $9.11 on May 12. It resulted in a $56,846 divestment by the insider. Krantz Jason Ronald added 450,000 shares at an average price of $11.54 on Nov 07. The insider now owns 450,000 shares following the transaction.
Valuation Metrics
The stock’s beta is 0.75. Besides these, the trailing price-to-sales (P/S) ratio of 6.59, the price-to-book (PB) ratio of 1.08, and the price-to-cash flow ratio of 54.55 may also be considered.
Financial Health
In the three months ended June 29, Definitive Healthcare Corp.’s quick ratio stood at 3.00, while its current ratio was 3.00, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.26, and the total debt-to-equity ratio was 0.27. On the profitability front, the trailing twelve-month gross margin is 81.40% percent. In the year ended June 29, EBITDA margin amounted to 10.57%, whereas operating margins totaled -18.20%. Based on annual data, DH earned $180.03 million in gross profit and brought in $222.65 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -2.00%. Return on equity (ROE) for the past 12 months was -1.00%.
In Definitive Healthcare Corp.’s quarter-end financial report for June 29, it reported total debt of $249.17 million against cash and short-term investments of $218.52 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. DH’s revenue rose 10.52% to $59.2 million during the quarter, while net income inched up to $60.96 million. While analysts expected Definitive Healthcare Corp. to report $0.05 quarterly earnings, the actual figure was $0.08 per share. During the quarter, the company generated $4.05 million in EBITDA. The liabilities of Definitive Healthcare Corp. were 649.4 million at the end of its most recent quarter ended June 29. The value of shareholders’ equity is $113.3 million.
Technical Picture
This quick technical analysis looks at Definitive Healthcare Corp.’s (DH) price momentum. With a historical volatility rate of 25.18%, the RSI 9-day stood at 25.42% on 18 August.
With respect to its five-day moving average, the current Definitive Healthcare Corp. price is down by -6.16% percent or -$0.65. At present, DH shares trade -14.14% below its 20-day simple moving average and -4.72% percent below its 100-day simple moving average. However, the stock is currently trading approximately -6.34% below its SMA50 and -37.26% below its SMA200.
Stochastic coefficient K was 18.89% and Stochastic coefficient D was 18.72%, while ATR was 0.54. Given the Stochastic reading of 16.19% for the 14-day period, the RSI (14) reading has been calculated as 33.70%. As of today, the MACD Oscillator reading stands at -0.46, while the 14-day reading stands at -0.76.
Analyst Ratings
Definitive Healthcare Corp. downgraded its rating on Definitive Healthcare Corp. (NASDAQ: DH) to a Neutral in a note to investors on July 24, 2023. The analysts firm previously had an Outperform rating on the stock.Definitive Healthcare Corp. (DH) has been rated Overweight by analysts. According to 0 brokerage firms, DH is a sell, and 8 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Definitive Healthcare Corp. stock as buy, with 6 recommending it as overweight.
With a median target price of $12.00, the current consensus forecast for the stock is $10.00 – $15.50. Based on these forecasts, analysts predict Definitive Healthcare Corp. (DH) will achieve an average price target of $12.54.
